What question did this study set out to answer?

The study aims to investigate whether MCP-1 levels in broncho-alveolar fluid and plasma can indicate the cause of lung injury post-HSCT.

C74-09 MCP-1 in Broncho-Alveolar Fluid and Plasma in Children With Lung Injury After Hematopoietic Stem Cell Transplant: A Transpire Study

View Full Paper

Ask AI

Bookmark

Authors

Prospective study examines MCP-1 levels in lung injury after HSCT, indicating local lung production.

The study aims to investigate whether MCP-1 levels in broncho-alveolar fluid and plasma can indicate the cause of lung injury post-HSCT.
Reviewed clinical data from 96 patients who underwent bronchoscopy for acute pulmonary events after HSCT.
Collected BALF and plasma samples, analyzing MCP-1 levels by ELISA.
Recorded macrophage percentages from BAL cytology reports.
MCP-1 levels were higher in BALF compared to plasma, with a weak correlation between the two.
Elevated BALF MCP-1 observed in patients with idiopathic pneumonia syndrome, but not reflected in plasma.
No correlation between macrophage percentages in BALF and MCP-1 levels in either fluid.

Strecker et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark